More than 40 million people worldwide are thought to be affected by Alzheimers disease
(AD). Of these, estimated less than 10% develop symptoms usually well before the age of …

More than 40 million people worldwide are thought to be affected by Alzheimers disease
(AD). Of these, estimated less than 10% develop symptoms usually well before the age of …

Alzheimer's disease (AD) is a multifactorial syndrome with a plethora of progressive,
degenerative changes in the brain parenchyma, but also in the cerebrovascular and …

Alzheimer's disease (AD) and cardiovascular disease (CVD) are strongly associated. Both
are multifactorial disorders with long asymptomatic phases and similar risk factors. Indeed …

Although preclinical research and observer studies on patients with atrial fibrillation
concluded that direct oral anticoagulants (DOACs) can protect against dementia like …

Oral anticoagulants are a critical component of stroke prevention, but carry a risk of brain
hemorrhage. These hemorrhagic complications tend to occur in elderly individuals …

Background Vascular risk factors such as atherosclerosis, diabetes, and elevated
homocysteine levels are strongly correlated with onset of Alzheimer's disease (AD) …

Background: Differences in management and outcomes of oral anticoagulant (OAC) use
may exist for people with and without dementia or cognitive impairment (CI). Objective: To …

Atrial fibrillation (AF) is a documented risk factor for dementia. However, it is unclear whether
oral anticoagulant (OAC) treatment can reduce the development of dementia or cognitive …

A 75-year-old man with a history of atrial fibrillation (AF) and anticoagulant therapy
presented with a headache. Cerebral amyloid angiopathy (CAA) was diagnosed after MRI of …